Henry Gomez Selected Research

Henry Gomez Research Topics

Disease

19	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2007
10	Neoplasms (Cancer) 01/2022 - 03/2009
5	Pathologic Complete Response 10/2021 - 11/2010
5	Triple Negative Breast Neoplasms 10/2021 - 07/2012
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2013 - 10/2009
2	Cardiotoxicity 01/2020 - 07/2012
2	Neutropenia 06/2013 - 07/2012
2	Thrombocytopenia (Thrombopenia) 03/2013 - 07/2012
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 10/2021
1	Diabetes Mellitus 01/2020
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2019
1	Exanthema (Rash) 01/2016
1	Infertility (Sterility) 02/2014
1	Eczema 01/2014
1	Diarrhea 06/2013
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2013
1	Anemia 03/2013
1	Fatigue 03/2013
1	Lymphopenia (Lymphocytopenia) 03/2013
1	Nausea 03/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 03/2013
1	Myalgia 03/2013
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2011
1	Lymphoma (Lymphomas) 10/2009
1	Adenocarcinoma 03/2009
1	Obesity 03/2009

Drug/Important Bio-Agent (IBA)

7	Trastuzumab (Herceptin)FDA Link 11/2021 - 05/2010
7	Lapatinib (GW572016)FDA Link 10/2021 - 05/2010
4	human ERBB2 proteinIBA 02/2017 - 05/2010
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2020
3	Estrogen ReceptorsIBA 10/2021 - 05/2011
3	Hormones (Hormone)IBA 10/2021 - 03/2008
3	AnthracyclinesIBA 12/2017 - 05/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2017 - 11/2010
3	ErbB Receptors (EGF Receptor)IBA 04/2016 - 05/2010
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 11/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2012
2	Phosphotransferases (Kinase)IBA 01/2018 - 05/2010
2	Fluorouracil (Carac)FDA LinkGeneric 02/2017 - 11/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2017 - 11/2010
2	Capecitabine (Xeloda)FDA Link 07/2013 - 05/2010
2	taxaneIBA 05/2011 - 01/2010
1	Biosimilar PharmaceuticalsIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 10/2021
1	HLA-DR Antigens (HLA-DR)IBA 10/2021
1	durvalumabIBA 10/2021
1	pembrolizumabIBA 10/2021
1	ParaffinIBA 01/2019
1	CarcinogensIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Estrogens (Estrogen)FDA Link 01/2018
1	PhosphoproteinsIBA 01/2018
1	Taxoids (Taxanes)IBA 12/2017
1	Epirubicin (Ellence)FDA LinkGeneric 02/2017
1	Epidermal Growth Factor (EGF)IBA 04/2016
1	Ointments (Pastes)IBA 01/2014
1	Sorafenib (BAY 43-9006)FDA Link 07/2013
1	plitidepsin (aplidine)IBA 03/2013
1	Transaminases (Aminotransferases)IBA 03/2013
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2013
1	Nucleic AcidsIBA 07/2012
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2012
1	Ifosfamide FDA LinkGeneric 07/2012
1	Etoposide (VP 16)FDA LinkGeneric 07/2012
1	Pharmaceutical PreparationsIBA 07/2012
1	AnthraquinonesIBA 07/2012
1	Investigational DrugsIBA 07/2012
1	pixantrone (BBR 2778)IBA 07/2012
1	Gemcitabine FDA Link 07/2012
1	Vinorelbine (Navelbine)FDA LinkGeneric 07/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2012
1	Rituximab (Mabthera)FDA Link 07/2011
1	Tyrosine Kinase InhibitorsIBA 05/2010
1	ixabepilone (BMS 247550)FDA Link 01/2010
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2009
1	Methotrexate (Mexate)FDA LinkGeneric 10/2009
1	exemestane (Aromasin)FDA Link 03/2008
1	Celecoxib (Celebrex)FDA Link 03/2008
1	Tamoxifen FDA LinkGeneric 03/2008
1	Messenger RNA (mRNA)IBA 03/2007

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2010
7	Drug Therapy (Chemotherapy) 12/2017 - 10/2009
3	Neoadjuvant Therapy 10/2021 - 05/2011
1	Immunotherapy 10/2021
1	Adjuvant Chemotherapy 01/2020
1	Intravenous Infusions 03/2013
1	Salvage Therapy 07/2012
1	Combination Drug Therapy (Combination Chemotherapy) 10/2009
1	Pancreatectomy 03/2009
1	Aftercare (After-Treatment) 03/2008